4//SEC Filing
GOREVIC JASON N 4
Accession 0001477449-24-000044
CIK 0001477449other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:09 PM ET
Size
29.1 KB
Accession
0001477449-24-000044
Insider Transaction Report
Form 4
Gorevic Jason N
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2024-03-01+2,915→ 625,779 total - Exercise/Conversion
Common Stock
2024-03-01+5,615→ 637,176 total - Exercise/Conversion
Common Stock
2024-03-01+62,004→ 699,180 total - Exercise/Conversion
Common Stock
2024-03-01+7,648→ 706,828 total - Sale
Common Stock
2024-03-04$14.52/sh−53,755$780,308→ 653,073 total - Award
Performance Stock Units
2024-03-01+63,393→ 63,393 total→ Common Stock (63,393 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−21,130→ 42,263 total→ Common Stock (21,130 underlying) - Exercise/Conversion
Common Stock
2024-03-01+21,130→ 622,864 total - Exercise/Conversion
Common Stock
2024-03-01+5,782→ 631,561 total - Exercise/Conversion
Performance Stock Units
2024-03-01−2,915→ 0 total→ Common Stock (2,915 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−5,782→ 0 total→ Common Stock (5,782 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−5,615→ 22,460 total→ Common Stock (5,615 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−62,004→ 124,008 total→ Common Stock (62,004 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−7,648→ 0 total→ Common Stock (7,648 underlying)
Footnotes (12)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F10]On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F11]On March 3, 2023, the reporting person was granted 186,012 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F12]On March 2, 2021, the reporting person was granted 22,944 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- [F5]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
- [F6]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F7]On March 1, 2024, the reporting person earned 63,393 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F8]On March 2, 2023, the reporting person earned 5,828 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
- [F9]On March 2, 2022, the reporting person earned 17,346 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
Documents
Issuer
Teladoc Health, Inc.
CIK 0001477449
Entity typeother
Related Parties
1- filerCIK 0001208500
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:09 PM ET
- Size
- 29.1 KB